Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingcai Meng

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Molecular Cancer|October 12, 2021
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectivesXiaoqi Mao, Jin Xu, Wei Wang, et al.
Clinical and Translational Medicine|March 30, 2021
Emerging roles of the solute carrier family in pancreatic cancerZijian Wu, Jin Xu, Chen Liang, et al.
Redox Biology|May 23, 2024
ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosisXiaoqi Mao, Jin Xu, Mingming Xiao, et al.
Journal for Immunotherapy of Cancer|August 30, 2019
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinomaYiyin Zhang, Jin Xu, Jie Hua, et al.
Cancers|December 18, 2019
Role of Damage DNA-Binding Protein 1 in Pancreatic Cancer Progression and ChemoresistanceYiyin Zhang, Yubin Lei, Jin Xu, et al.
Experimental & Molecular Medicine|April 4, 2018
Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are goingChen Liang, Si Shi, Qingcai Meng, et al.
BMC Cancer|July 21, 2022
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancerSiyuan Lu, Jie Hua, Jiang Liu, et al.
Surgery|February 1, 2024
CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in pancreatic cancerAbudureyimu Tuerhong, Jin Xu, Wei Wang, et al.
Ebiomedicine|April 12, 2024
Intratumoral CD38<sup>+</sup>CD19<sup>+</sup>B cells associate with poor clinical outcomes and immunosuppression in patients with pancreatic ductal adenocarcinomaHeng Zhu, Jin Xu, Wei Wang, et al.
Gut|October 16, 2019
Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancerChen Liang, Si Shi, Yi Qin, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Molecular Cancer|October 12, 2021
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectivesXiaoqi Mao, Jin Xu, Wei Wang, et al.
Clinical and Translational Medicine|March 30, 2021
Emerging roles of the solute carrier family in pancreatic cancerZijian Wu, Jin Xu, Chen Liang, et al.
Redox Biology|May 23, 2024
ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosisXiaoqi Mao, Jin Xu, Mingming Xiao, et al.
Journal for Immunotherapy of Cancer|August 30, 2019
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinomaYiyin Zhang, Jin Xu, Jie Hua, et al.
Cancers|December 18, 2019
Role of Damage DNA-Binding Protein 1 in Pancreatic Cancer Progression and ChemoresistanceYiyin Zhang, Yubin Lei, Jin Xu, et al.
Experimental & Molecular Medicine|April 4, 2018
Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are goingChen Liang, Si Shi, Qingcai Meng, et al.
BMC Cancer|July 21, 2022
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancerSiyuan Lu, Jie Hua, Jiang Liu, et al.
Surgery|February 1, 2024
CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in pancreatic cancerAbudureyimu Tuerhong, Jin Xu, Wei Wang, et al.
Ebiomedicine|April 12, 2024
Intratumoral CD38<sup>+</sup>CD19<sup>+</sup>B cells associate with poor clinical outcomes and immunosuppression in patients with pancreatic ductal adenocarcinomaHeng Zhu, Jin Xu, Wei Wang, et al.
Gut|October 16, 2019
Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancerChen Liang, Si Shi, Yi Qin, et al.
Pageof 9